Intra-Cellular Therapies logo
Intra-Cellular Therapies ITCI
$ 68.49 -3.51%

Intra-Cellular Therapies Operating Income 2011-2024 | ITCI

Annual Operating Income Intra-Cellular Therapies

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-159 M -264 M -286 M -231 M -154 M -162 M -103 M -118 M -106 M -31 M -26.3 M -16.4 M -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-16.4 M -286 M -138 M

Quarterly Operating Income Intra-Cellular Therapies

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-21 M - -29.7 M -47.2 M -48.4 M - -55.6 M -87.9 M -72.7 M - -77.3 M -69.1 M -53.2 M - -55.9 M -64.9 M -49.1 M - -36.4 M -39.2 M -36.7 M - -43.4 M -39.2 M -37.1 M - -23.8 M -18.6 M -27.8 M - -30.2 M -31.5 M -28.5 M - -32.3 M -21.7 M -22.4 M - -6.5 M -4.61 M -4.57 M - -4.79 M -8.05 M -5.4 M - -2.22 M - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-2.22 M -87.9 M -35.3 M